Imagene AI to Demonstrate Real-Time Biomarker Detection From H&E Images at ASCO 2022 CHICAGO, June 01, 2022 (GLOBE NEWSWIRE) -- Imagene AI, an emerging leader in the field of AI-based precision medicine for cancer, today announced that it will demonstrate its molecular and spatial...

Imagene AI CEO Dean Bitan to Speak at FORTUNE Brainstorm Health 2022 Company co-founder will be interviewed May 11 by Bryan Walsh of Vox on the show’s mainstage Imagene’s deep learning algorithms use digital biopsy images to deliver real-time molecular and spatial...

Imagene AI Secures $21.5 Million to Push the Boundaries of Precision Medicine for Cancer Imagene's proprietary deep learning algorithms reduce the time required for biomarkers detection from several weeks to two minutes – allowing more cancer patients to receive the most effective...